A Study of CLE-400 (Topical Gel) for the Treatment of Chronic Pruritus in Adult Subjects With Notalgia Paresthetica
Clinical trial NCT06262607 · COMPLETED
Trial details
- NCT number
- NCT06262607
- Sponsor
- Clexio Biosciences Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-29
- Primary completion
- 2024-11-06
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.